shl-telemedicine.com (SHLT) EV/EBITDA Multiple

Corporate emblem and logo of SHL Telemedicine, Ltd. (SHLT)

SHL Telemedicine Ltd. (SHLT) provides remote medical services, leveraging stable cash flows from low-cost European cardiac monitoring contracts. This chart's price action serves as an indicator, showing an EV/EBITDA of , although regulatory complexities and the dominance of tech giants hinder expansion. The business is protected by licenses and patents, requiring high patient trust and a staff of certified medical professionals.

SHLT SHL Telemedicine, Ltd.: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization in the range 07/04/2022 - 11/17/2026

Analytical breakdowns for SHL Telemedicine (SHLT)

- market price and analyst price targets:
Initial company analysis:SHLT (shl-telemedicine.com)
Manufactured products of shl-telemedicine.com

SHL Telemedicine Ltd. (SHLT) maintains its leadership in the high-tech cardiac monitoring segment, avoiding price wars through premium integration quality. An analysis of the EV/EBITDA ratio, accounting for operating profit and depreciation, allows for a valuation of the entire business relative to its ability to generate cash flow before interest and taxes. A decrease in this metric confirms the efficiency of asset capitalization and the company's fundamental stability.